Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06516003 · ClinicalTrials.gov registry record · NA

VR for Lac Repairs in Peds Emergency Department

A NA study, sponsored by Eastern Virginia Medical School.

Completed
Registry status
NA
Development phase
91
Enrollment target

NCT06516003: Completed NA study, sponsored by Eastern Virginia Medical School.

NCT06516003 is a NA study that has completed, run by Eastern Virginia Medical School. The registered enrollment target is 91 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06516003, a NA study, has completed, sponsored by Eastern Virginia Medical School.

COMPLETED
Registry status
NA
Development phase
91 participants
Enrollment target

Study Summary

The goal of the clinical trial is to compare virtual reality to standard of care for laceration repairs in the pediatric emergency department. The main question it aims to answer is: -Does virtual reality decrease pain and anxiety scores compared to standard of care for laceration repairs in the pediatric emergency department? Participants who meet the age and other inclusion criteria will be enrolled by research staff. They will complete a brief paper survey along with their guardians and the provider doing the laceration repair. The surveys will be completed after the laceration repair is finished.

Primary Outcome

Using Wong Baker Faces Pain Scale

Interventions

  • BEHAVIORAL Standard of Care
  • DEVICE Immersive Virtual Reality Goggles

Trial Details

FieldValue
Enrollment Target 91 participants
Start Date 2022-02-01
Est. Completion 2023-03-30
Phase NA
Eastern Virginia Medical School

36 total trials

What the finished NCT06516003 record still lists

NCT06516003 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.

NCT06516003 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06516003 about?

NCT06516003 is a clinical study titled "VR for Lac Repairs in Peds Emergency Department". The goal of the clinical trial is to compare virtual reality to standard of care for laceration repairs in the pediatric emergency department. The main question it aims to answer is: -Does virtual reality decrease pain and anxiety scores compared to standard of care for laceration repairs in the pe...

What is the current status of trial NCT06516003?

This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2022-02-01. Estimated completion is 2023-03-30.

What interventions are being tested in trial NCT06516003?

The interventions under investigation include: Standard of Care (BEHAVIORAL), Immersive Virtual Reality Goggles (DEVICE).

Who is sponsoring clinical trial NCT06516003?

This trial is sponsored by Eastern Virginia Medical School, which has 36 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06516003's enrollment target sits among peer trials

91 939th of 2000 higher than 1,060 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02671448 · 91 participants · NA

    Pilot Trial of Homebound Stem Cell Transplantation

  • NCT04835857 · 91 participants

    Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices

  • NCT05184842 · 91 participants · Phase 2

    Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML

  • NCT05685173 · 91 participants · Phase 1

    A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06516003, the US trial registry maintained by the National Library of Medicine. NCT06516003 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.